COMP <GO>
MODD vs PAVM // ALTMAN Z-SCORE & DEBT/EQUITY
Modular Medical Inc. (NASDAQ) VS. PAVmed Inc. (NASDAQ) • 15-METRIC TALLY: MODD 3
— PAVM 0
■ METRIC PARITY
LAST: $1.72 (-9.95%) • MKT CAP: $16.3M
balance-sheet
—
LAST: $1.97 (-5.29%) • MKT CAP: $15.8M
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MODD VS. PAVM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MODD | PAVM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | -30.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -65.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | MODD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.2 | 26.5 | +12.63 | MODD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.3M | $15.8M | $580.9K | MODD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MODD REV | PAVM REV | MODD GROSS % | PAVM GROSS % | MODD FCF | PAVM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $71.0K | — | -50.0% | -$27.7M | -$5.2M |
| FY 2024 | $0 | $3.0M | — | -50.0% | -$18.2M | -$33.6M |
| FY 2023 | $0 | $2.5M | — | — | -$14.0M | -$52.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MODD // BETA —
PAVM // BETA —